Diabetes

Results from a recent ELLIPSE trial indicate superiority in reducing blood sugar when compared to the placebo.

Increase adherence by matching technology to each patient's unique needs.

Consumers are using test strips that might lead to inaccurate results. 

Eli Lilly creates generic Humalog priced 50% lower 

Rounding up the news you need to know to start the new year.

GPS-based dietary prompts, continuous glucose monitors among the devices poised to revolutionize diabetes treatment and patient management. 

Drug Topics spoke to several community pharmacists  about their diabetes education programs and how they can be a revenue stream. Here’s their advice for other pharmacists.

A study has found that pharmacists in primary care networks can help lower A1c levels. 

Diets that involve fasting could impair the action of insulin and increase the risk of developing diabetes.

Some patients with type 2 diabetes and chronic kidney disease can be safely treated with metformin. 

High levels of vitamin D, 50 ng/ml, have been linked to a lower incidence of diabetes in a long-term study.

Insulin glargine should not be used past 28 days after the vial is first used, but 80% of patients do. 

Diabetes drug empagliflozin reduces fat levels in type 2 patients, which may reduce risk of severe liver disease.

Missing teeth could be a signal that diabetes may be developing.

The immune system could play a beneficial role in regulating insulin, according to a study from Switzerland.

Patients will soon have one less option when selecting insulin.

Type 1 diabetes can present in adults, which can lead to misdiagnosis and unsuccessful treatment.

Having a clinical pharmacist integrated into a medical home benefits diabetes and hypertension patients.

Several state attorneys general are asking pointed questions about why insulin prices are rising.

Young people with diabetes may do better with insulin pumps than they do with injections.

Why it's a good time to become more involved in diabetes education.

Interventions by pharmacists can help improve the results of diabetes clinical trials.

Good glucose control can help children and teens with type 1 diabetes boost their quality of life.

Easy-to-swallow bits of news from around the world of pharmacy.

Studies have linked type 2 diabetes drug to increased risk of foot and leg amputations.

Drug makers are starting plans to help patients pay for diabetes drugs.

Supervalu’s diabetes campaign offers risk assessments, screening, and food education.

New class of glucose-lowering agents lowers hospitalization and death rates even in Type 2 patients without heart disease.

This week, take a look at studies and news on supplements, depression, opioids, and more. Small doses is the news you need in a way that works for you.